Patents by Inventor Sandra U. KUCERA

Sandra U. KUCERA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091201
    Abstract: The disclosure provides for improved pharmaceutical compositions containing deferasirox (DFX) and methods of manufacturing the same. In particular, the compositions are prepared using thermokinetic compounding and provide improved properties as well as more efficient methods of manufacture.
    Type: Application
    Filed: November 24, 2023
    Publication date: March 21, 2024
    Applicant: AustinPx, LLC
    Inventors: Dave A. MILLER, Justin M. KEEN, Sandra U. KUCERA
  • Patent number: 11878005
    Abstract: The disclosure provides for improved pharmaceutical compositions containing deferasirox (DFX) and methods of manufacturing the same. In particular, the compositions are prepared using thermokinetic compounding and provide improved properties as well as more efficient methods of manufacture.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: January 23, 2024
    Assignee: AustinPx, LLC
    Inventors: Dave A. Miller, Justin M. Keen, Sandra U. Kucera
  • Publication number: 20190167643
    Abstract: The disclosure provides for improved pharmaceutical compositions containing deferasirox (DFX) and methods of manufacturing the same. In particular, the compositions are prepared using thermokinetic compounding and provide improved properties as well as more efficient methods of manufacture.
    Type: Application
    Filed: February 6, 2019
    Publication date: June 6, 2019
    Applicant: DISPERSOL TECHNOLOGIES, LLC
    Inventors: Dave A. MILLER, Justin M. KEEN, Sandra U. KUCERA
  • Patent number: 10265301
    Abstract: The disclosure provides for improved pharmaceutical compositions containing deferasirox (DFX) and methods of manufacturing the same. In particular, the compositions are prepared using thermokinetic compounding and provide improved properties as well as more efficient methods of manufacture.
    Type: Grant
    Filed: June 17, 2016
    Date of Patent: April 23, 2019
    Assignee: DISPERSOL TECHNOLOGIES, LLC
    Inventors: Dave A. Miller, Justin M. Keen, Sandra U. Kucera
  • Patent number: 10258608
    Abstract: The disclosure provides for improved pharmaceutical compositions containing deferasirox (DFX) and methods of manufacturing the same. In particular, the compositions are prepared using thermokinetic compounding and provide improved properties as well as more efficient methods of manufacture.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: April 16, 2019
    Assignee: DISPERSOL TECHNOLOGIES, LLC
    Inventors: Dave A. Miller, Justin M. Keen, Sandra U. Kucera
  • Publication number: 20170333404
    Abstract: The disclosure provides for improved pharmaceutical compositions containing vemurafenib and methods of manufacturing the same. In particular, the compositions are prepared using thermokinetic compounding and provide improved properties as well as more efficient methods of manufacture.
    Type: Application
    Filed: November 3, 2015
    Publication date: November 23, 2017
    Applicant: DISPERSOL TECHNOLOGIES, LLC
    Inventors: Dave Alan MILLER, Justin Martin KEEN, Chris BROUGH, Sandra U. KUCERA, Daniel J. ELLENBERGER
  • Publication number: 20170296514
    Abstract: The disclosure provides for improved pharmaceutical compositions containing deferasirox (DFX) and methods of manufacturing the same. In particular, the compositions are prepared using thermokinetic compounding and provide improved properties as well as more efficient methods of manufacture.
    Type: Application
    Filed: June 28, 2017
    Publication date: October 19, 2017
    Applicant: DISPERSOL TECHNOLOGIES, LLC
    Inventors: Dave A. MILLER, Justin M. KEEN, Sandra U. KUCERA
  • Publication number: 20170027911
    Abstract: The disclosure provides for improved pharmaceutical compositions containing deferasirox (DFX) and methods of manufacturing the same. In particular, the compositions are prepared using thermokinetic compounding and provide improved properties as well as more efficient methods of manufacture.
    Type: Application
    Filed: June 17, 2016
    Publication date: February 2, 2017
    Applicant: Dispersol Technologies, LLC
    Inventors: Dave A. MILLER, Justin M. KEEN, Sandra U. KUCERA